SDHB缺陷型肾细胞癌新见解:病例系列全面分析及新突变位点
该研究纳入2016至2022年本院诊断的5例SDHB缺陷型肾细胞癌患者,通过光镜、免疫组化、超微结构分析和Sanger测序进行系统研究。患者中位年龄34岁,肿瘤平均直径7cm,所有肿瘤SDHB免疫组化表达缺失,均证实SDHB胚系突变,其中1例携带既往未报道的exon 7 c.697_700del新突变。PD-L1(SP263)联合阳性评分平均18,电镜显示显著线粒体异常,随访1例转移死亡。
要点
- SDHB缺陷型肾细胞癌形态多样,可呈实性、巢状、腺管状、乳头状及微乳头结构。
- 所有病例SDHB免疫组化表达缺失,均检出SDHB胚系突变。
- 发现1例SDHB exon 7 c.697_700del新突变,拓展了该肿瘤的遗传变异谱。
核心结论
- 本研究拓展了SDHB缺陷型肾细胞癌的形态学谱,并报道了SDHB基因一个新的点突变,为该肿瘤提供了遗传变异谱。
研究设计与样本
- 回顾性病例系列研究,纳入2016至2022年本院诊断的5例SDHB缺陷型肾细胞癌患者。
- 采用光镜、免疫组化、超微结构分析和Sanger测序进行系统研究。
主要发现
- 患者中位年龄34岁,男性2例、女性3例;肿瘤边界清楚,平均直径7cm。
- 组织学呈实性、巢状、腺管状或管状伴囊性变,细胞嗜酸性、纤细或泡状;1例见明显乳头状结构伴灶性泡沫细胞聚集,3例见灶性微乳头结构。
- 2例患者具有国际泌尿病理学会3级核;所有病例肿瘤细胞SDHB免疫组化表达缺失。
- 所有患者PD-L1(SP263)联合阳性评分平均值为18;电镜显示显著线粒体异常。
- 基因检测证实所有肿瘤存在SDHB胚系突变,其中1例为既往未报道的exon 7 c.697_700del新突变;随访1例发生转移并死亡。
临床怎么用
- 对疑似SDHB缺陷型肾细胞癌应常规行SDHB免疫组化筛查,表达缺失者建议行SDHB胚系基因检测。
- 病理诊断需注意该肿瘤形态多样,可呈乳头状或微乳头结构,避免误诊。
局限性
- 本研究为单中心小样本病例系列(5例),研究结果需更大样本验证。
- 随访信息有限,仅1例发生转移并死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Succinate dehydrogenase-deficient renal cell carcinoma (RCC) is a newly classified subtype of RCC in the World Health Organization classification of urinary and male genital tumours. However, systemic reports on this tumor are limited. OBJECTIVE.—: To give new insights into the clinicopathologic and molecular features of succinate dehydrogenase complex iron sulfur subunit B (SDHB)-deficient RCC. DESIGN.—: Data from 5 SDHB-deficient RCC patients diagnosed at our hospital between 2016 and 2022 were collected and studied through light microscopy, immunohistochemistry (IHC), ultrastructural analysis, and Sanger sequencing. RESULTS.—: The median age of patients was 34 years; 2 were male and 3 were female. Grossly, the tumors were well defined, with an average diameter of 7 cm. Histologically, the cells were arranged in diverse patterns: solid, nested, glandular, or tubular with scattered cysts containing eosinophilic, wispy, or bubbly appearances. One patient's tumor exhibited an obvious papillary structure with focal aggregation of foam cells, and 3 tumors displayed focal micropapillary structures. Two patients presented with high-grade International Society of Urologic Pathology 3 nuclei. The tumor cells in all cases lacked SDHB expression by IHC stain. In addition, the average value of the combined positive score of programmed death ligand-1 (PD-L1, SP263) in all patients was 18. Electron microscopy revealed significant mitochondrial abnormalities. Genetic testing confirmed SDHB germline mutations in all tumors. One patient's tumor presented a novel, previously unreported mutation: c.697_700del in exon 7. Follow-up revealed metastasis in 1 patient, leading to mortality. CONCLUSIONS.—: Our findings broaden the morphologic spectrum and highlight a new point mutation in the SDHB gene, providing a genetic change spectrum for this tumor entity.
引用
- Wu J, Wang Y, Yang L, et al. New Insights Into Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Comprehensive Analysis of a Case Series With Novel Mutation Sites. Arch Pathol Lab Med. 2025. PMID: 41269775. doi:10.5858/arpa.2025-0233-OA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。